M4MM

Jushi Reports Q3 2026 Financial Results

BOCA RATON – Jushi Holdings Inc. released its third-quarter 2026 financial results, reporting $70.5 million in revenue, a 7% YoY gain driven by record wholesale volume and retail growth across several key states, even as ...

Verano Reports Q3 2026 Financial Results

CHICAGO – Verano Holdings Corp. reported $212.4 million in third-quarter revenue, a 5% increase YoY. The figure came in modestly below analyst estimates of $216.4 million and trailed the $217.9 million posted last quarter, but ...

Verano Reports Q3 2026 Financial Results

CHICAGO – Verano Holdings Corp. reported $212.4 million in third-quarter revenue, a 5% increase YoY. The figure came in modestly below analyst estimates of $216.4 million and trailed the $217.9 million posted last quarter, but ...

Jushi Reports Q3 2026 Financial Results

BOCA RATON – Jushi Holdings Inc. released its third-quarter 2026 financial results, reporting $70.5 million in revenue, a 7% YoY gain driven by record wholesale volume and retail growth across several key states, even as ...

Verano Reports Q3 2026 Financial Results

CHICAGO – Verano Holdings Corp. reported $212.4 million in third-quarter revenue, a 5% increase YoY. The figure came in modestly below analyst estimates of $216.4 million and trailed the $217.9 million posted last quarter, but ...

Compass Builds a Commercial Case for COMP360

NEW YORK – Compass Pathways is advancing COMP360, its proprietary synthetic psilocybin for treatment-resistant depression (TRD), through a rolling FDA New Drug Application, with a commercial launch targeted for H1 2027. Alongside the regulatory push, ...

Dutch Medical Cannabis Giant Bedrocan Goes Bankrupt

GRONINGEN – The District Court of Northern Netherlands officially declared Bedrocan bankrupt, after the company sought a suspension of payments in late September, ending a more than two-decade run as the country's sole licensed medical ...

DEA Opens Schedule III Registration Path for Medical Cannabis Operators

WASHINGTON – The Drug Enforcement Administration’s Diversion Control Division has launched the application process, making DEA Form 225 available to state-licensed medical Cannabis manufacturers, distributors, and analytical labs. Manufacturers cover cultivation, production, processing, packaging, labeling ...

Subscribe To Our Newsletter